The Vine

While the world has undergone a collective trauma from a global pandemic, science has shown that psychedelics offer therapeutic support for mental health conditions. 

Despite still listed as a Schedule I controlled substance, psychedelics have been all over the news with ongoing clinical trials with how these plant medicines can help a wide array of conditions including PTSD and dealing with terminal illness. Some cities in California, Colorado, and Michigan are decriminalizing psychedelics, and voters are joining in on the movement. 

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is hosting a virtual panel discussion titled "Can Psychedelics Help Save America?" on 10/28/20. For more info and to register, visit THIS LINK.

Panelists Include: 

• Introduction: Carmel Shachar, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
• Ifetayo Harvey, Founder, People of Color Psychedelic Collective; Marketing Coordinator, Drug Policy Alliance
• Larissa J. Maier, Post-doctoral Scholar, UCSF School of Pharmacy; Member, Core Research Team, Global Drug Survey; Host, Psychedelic and Entheogen Academic Council (PEAC), UCSF
• Patricia Zettler, Associate Professor of Law, Ohio State Moritz College of Law; Faculty Member, Drug Enforcement and Policy Center
• Dustin Marlan, Assistant Professor of Law, University of Massachusetts School of Law; Director, Community Development Clinic
• Moderator: Mason Marks, Assistant Professor of Law, Gonzaga University; Fellow in Ethics of Technological and Biomedical Innovation, Edmond J. Safra/Petrie-Flom Centers, Harvard University

PMP will keep you posted on all of the latest news and events in psychedelics. Follow our podcast The Vine wherever you get your podcasts for insightful discussions around the changing landscape of plant medicine.